Explain the concepts related to viruses, antibiotics, vaccines, and public health measures, as outlined in Activities 4 and 6.

Here are the answers to Activity 4 and Activity 6. Activity 4 4.1: A: Spike protein* B: Genetic material* (RNA) 4.2: Antibiotics are effective against bacteria, not viruses. Viruses have a different structure and replication mechanism that antibiotics do not target. 4.3: A vaccine introduces a weakened or inactive form of the pathogen, or parts of it, into the body. This stimulates the immune system to produce antibodies and memory cells without causing the actual disease. If the body encounters the real pathogen later, the immune system can quickly recognize and fight it off. 4.4: Vaccine development is a lengthy process involving several stages: Research and development*: Identifying the pathogen and potential vaccine candidates. Pre-clinical trials*: Testing on animals for safety and immune response. Clinical trials*: Three phases of human trials to assess safety, dosage, and efficacy. Regulatory approval*: Review by health authorities. Manufacturing and distribution*: Large-scale production and delivery. Each stage requires significant time to ensure the vaccine is both safe and effective. 4.5: Wearing masks* in public spaces. Maintaining social distancing* (e.g., 1.5 to 2 meters apart). Frequent hand washing* with soap and water or using alcohol-based sanitizers. Avoiding large gatherings* and crowded places. 4.6: People with pre-existing conditions (e.g., diabetes, heart disease, respiratory illnesses, compromised immune systems) often have a weaker immune response or their bodies are already under stress. This makes them less able to fight off the coronavirus infection, leading to more severe symptoms and a higher risk of complications. Activity 6 6.1: a) 3: Cytoplasm* b) 5: Cell wall* c) 6: Flagellum* 6.2: Part 4 is the cell membrane. Its function is to regulate the movement of substances into and out of the bacterial cell. 6.3: Bacteria develop resistance through genetic mutations that allow them to survive exposure to antibiotics. These mutations can alter the antibiotic's target, produce enzymes that inactivate the antibiotic, or pump the antibiotic out of the cell. Humans contribute to this phenomenon by overusing or misusing antibiotics (e.g., not completing the full course, using them for viral infections), which creates a selective pressure for resistant bacteria to survive and multiply, passing on their resistance genes. 6.4: Structure 6 is a plasmid, which is a small, circular piece of DNA separate from the main bacterial chromosome. In the manufacture of insulin, the human gene for insulin is isolated and then inserted into a bacterial plasmid using genetic engineering techniques. This recombinant plasmid is then introduced into bacteria. The bacteria, now containing the human insulin gene, are cultured and will express this gene, producing large quantities of human insulin. 3 done, 2 left today. You're making progress.